BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21281879)

  • 1. Forced expiratory flow between 25% and 75% of vital capacity may be a marker of bronchial impairment in allergic rhinitis.
    Ciprandi G; Cirillo I
    J Allergy Clin Immunol; 2011 Feb; 127(2):549; discussion 550-1. PubMed ID: 21281879
    [No Abstract]   [Full Text] [Related]  

  • 2. Bronchial hyperreactivity and spirometric impairment in patients with allergic rhinitis.
    Cirillo I; Vizzaccaro A; Tosca MA; Negrini S; Negrini AC; Marseglia G; Ciprandi G
    Monaldi Arch Chest Dis; 2005 Jun; 63(2):79-83. PubMed ID: 16128221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of forced expiratory flow at 25-75% as an early marker of small airways impairment in subjects with allergic rhinitis.
    Marseglia GL; Cirillo I; Vizzaccaro A; Klersy C; Tosca MA; La Rosa M; Marseglia A; Licari A; Leone M; Ciprandi G
    Allergy Asthma Proc; 2007; 28(1):74-8. PubMed ID: 17390762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of the bronchial tonus, basal and following bronchodilators, in subjects with allergic rhinitis].
    Vignale L; Parentini GC; Rossi PC
    Minerva Med; 1989 May; 80(5):469-74. PubMed ID: 2747974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of peak expiratory flow rate in allergic rhinitis and mild asthma: relationship to maximal airway narrowing.
    Prieto L; Gutiérrez V; Morales C; Perpiñan J; Inchaurraga I
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):151-8. PubMed ID: 9494447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of allergic rhinitis on asthma in children: effects on bronchial hyperreactivity.
    Ciprandi G; Tosca MA; Cirillo I; Capasso M
    Allergy; 2010 Sep; 65(9):1199-201. PubMed ID: 20132159
    [No Abstract]   [Full Text] [Related]  

  • 7. Measurement of response to methacholine inhalation challenge in asthma and allergic rhinitis. PC20 or PC35FEV1?
    Prieto L; Marín J
    Allergol Immunopathol (Madr); 1990; 18(5):285-9. PubMed ID: 2097895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of intranasal corticosteroids on asthma control and quality of life in allergic rhinitis with mild asthma.
    Scichilone N; Arrigo R; Paternò A; Santagata R; Impellitteri S; Braido F; Baiardini I; Battaglia S; Walter Canonica G; Bellia V
    J Asthma; 2011 Feb; 48(1):41-7. PubMed ID: 21050027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of FEF25-75 as an early marker of bronchial impairment in patients with seasonal allergic rhinitis.
    Ciprandi G; Cirillo I; Klersy C; Marseglia GL; Vizzaccaro A; Pallestrini E; Tosca M
    Am J Rhinol; 2006; 20(6):641-7. PubMed ID: 17181110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between airway sensitivity to adenosine 5' monophosphate and the shape of the concentration-response curve to methacholine in subjects with allergic rhinitis.
    Prieto L; Gutiérrez V; Marín J
    Respir Med; 2001 Jun; 95(6):457-63. PubMed ID: 11421502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired FEF25-75 values may predict bronchial reversibility in allergic children with rhinitis or asthma.
    Ciprandi G; Capasso M; Leonardi S; Lionetti E; La Rosa M; Salpietro C; Miraglia Del Giudice M; Cirillo I; Tosca M; Marseglia GL
    J Biol Regul Homeost Agents; 2012; 26(1 Suppl):S19-25. PubMed ID: 22691246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The lower airway pathology of rhinitis.
    Ciprandi G; Cirillo I
    J Allergy Clin Immunol; 2006 Nov; 118(5):1105-9. PubMed ID: 17088136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bronchodilation test in allergic adolescents.
    Marseglia GL; Marchi A; Caimmi D; Caimmi S; Di Gioacchino M; Ciprandi G
    J Biol Regul Homeost Agents; 2008; 22(4):267-70. PubMed ID: 19036230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial lability in allergic rhinitis.
    Walter S
    Indian J Physiol Pharmacol; 1992 Jul; 36(3):177-80. PubMed ID: 1473847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methacholine inhalation challenge. Practical consequences of using duplicate spirograms after each concentration.
    Prieto L; Marín J
    Ann Allergy; 1993 Jun; 70(6):487-90. PubMed ID: 8507045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower airways may also be affected in asymptomatic patients with recent onset of allergic rhinitis.
    Ciprandi G; Cirillo I; Klersy C
    Laryngoscope; 2010 Jul; 120(7):1288-91. PubMed ID: 20578230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin C on histamine bronchial responsiveness of patients with allergic rhinitis.
    Bucca C; Rolla G; Oliva A; Farina JC
    Ann Allergy; 1990 Oct; 65(4):311-4. PubMed ID: 2221490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral airways obstruction in patients with rhinitis.
    Lidington RE; Cotton DJ; Graham BL; Dosman JA
    Ann Allergy; 1979 Jan; 42(1):28-33. PubMed ID: 760623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atopic disease and exhaled nitric oxide in an unselected population of young adults.
    van Asch CJ; Balemans WA; Rovers MM; Schilder AG; van der Ent CK
    Ann Allergy Asthma Immunol; 2008 Jan; 100(1):59-65. PubMed ID: 18254484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nasal airflow recovery after decongestion test is associated with bronchial hyperreactivity in patients with allergic rhinitis.
    Ciprandi G; Cirillo I; Klersy C; Vizzaccaro A; Tosca MA; Marseglia GL
    Otolaryngol Head Neck Surg; 2006 Feb; 134(2):255-9. PubMed ID: 16455374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.